Novo Nordisk will donate a licence to its small molecule compound library to the National Center for Drug Screening (NCDS) affiliated to Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The centre will use the library – both the actual compounds and an associated database – for screening activities to identify new drug candidates for infectious tropical diseases that affect people in poor countries.
Discuss   Add this link to...  Bury

Comments Who Voted Related Links